FN vs NVDA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Fabrinet exhibits a critical disconnect between its market price ($720.19) and its fundamental value, with a weak Piotroski F-Score of 3/9 indicating deteriorating financial health trends. While the company boasts impressive revenue growth (35.9%) and a pristine balance sheet with zero debt, it is trading at a massive premium to its Intrinsic Value ($307.98) and Graham Number ($119.69). The combination of a high P/E ratio (68.98), bearish insider selling, and a failing technical trend suggests the stock is currently in a valuation bubble.
NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.
Compare Another Pair
Related Comparisons
FN vs NVDA: Head-to-Head Comparison
This page compares Fabrinet (FN) and NVIDIA Corporation (NVDA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.